Global Synthetic Biology Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
MarketResearch.biz delivers in-depth insights on the global synthetic biology market in its upcoming report titled, “Global Synthetic Biology Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global synthetic biology market is estimated to register a CAGR of XX.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global synthetic biology market report has been segmented on the basis of product, application, technology, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Synthetic biology is design and construction of new biological modules through the amalgamation of domains such as genetic engineering, molecular biology, evolutionary biology, etc, which helps in experiments related to reading and rewriting human or animal DNA. This stream of science aids in construction, testing, and designing of artificial organisms, cells, and to modify or redesign existing biological systems.
Increasing demand for synthetic biology for various applications in healthcare, food & beverages, and other industries is a major factor driving growth of the global synthetic biology market. In addition, increasing adoption of synthetic biology for biofuels and genomic engineering is another factor driving growth of the global market. Moreover, increasing investments and funding for research and development in synthetic biology by public and private players is another factor expected to further propel growth of the global market to a significant extent over the forecast period.
Release of synthetic biology organisms either accidently or purposefully can cause harmful effect to the ecological system. This is a major factor restraining growth of the global synthetic biology market. However, proper care and government regulation & safety measures are ensured to take care of it. Technological advancements towards development of cost-effective vaccines to prevent infectious diseases is expected to create opportunities for major manufacturers in the global market over the forecast period.
The market in North America accounts for highest revenue share in the global synthetic biology market and is expected to maintain its dominance over the forecast period. Presence of advanced healthcare infrastructure, government investments, and presence of major players in countries in this region are major factors driving growth of the North America synthetic biology market. The Europe Market accounts for second highest share in terms of revenue in the global market. The Europe synthetic biology market is expected to witness significant growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific synthetic biology market is expected to witness highest growth and is projected to register a CAGR of XX.X% over the next 10 years.
Global synthetic biology market segmentation:
Segmentation on the basis of product:
- Core Products
- Enabling product
Segmentation on the basis of application:
Segmentation on the basis of technology:
- DNA sequencing
- Genome engineering
- Biological Components and Integrated Systems
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Thermo Fisher Scientific
- Amyris Inc.
- Algenol Biofuels, Inc.
- Merck KGaA
- Intrexon Corporation
- Genscript Biotech Corporation
- Agilent Technologies
- New England Biolabs (NEB)
- Ginkgo Bioworks
- Integrated Dna Technologies (IDT)
- Synthetic Genomics
- Twist Bioscience
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!